Abstract: The present technology generally relates to a method for modulating in situ production of energy by a biological tissue. The method comprises stimulating the biological tissue by exposing the biological tissue to a photostimulated biophotonic composition for a time sufficient to initiate the production of energy by the biological tissue.

Abstract: An anti-rotation device for suspending a load under a machine for lifting and moving this load includes a sling system provided with a fastener to the machine. It further includes a spreader beam, having a main longitudinal axis and a yaw rotation vertical transverse axis, including: a system for upper fastening to the sling system so it can be suspended in a substantially horizontal arrangement of its main longitudinal axis and free about its vertical transverse axis under the machine using the sling system; a system for lower fastening to the load, allowing driving of the load by the spreader beam about its vertical transverse axis. The spreader beam includes a propulsion unig disposed in such a way as to engage its rotation, selectively in one direction or in the other, about its vertical transverse axis when it is suspended from the machine via the sling system.

Abstract: The present document describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for use in the treatment of skin and soft tissue wounds that have either or both non-resistant and resistant infections.

Abstract: In various aspects, the present disclosure relates to fibers and fabric media comprising photoactivatable agents and to fibers and fabric media that are photoactivatable by photoactivation of the photoactivatable agents. In some instances, the fibers and the fabric media have photoactivatable agents present on their surface (e.g., the fiber/fabric is coated or sprayed with the photoactivatable agents or the fiber/fabric is dipped into a composition or a formulation comprising the photoactivatable agent). In other instances, the photoactivatable agents are incorporated into the materials making the fibers (e.g., the photoactivatable agents are mixed/compounded with the materials making the fibers). The photoactivatable fibers of the present disclosure comprise at least one thermoplastic polymer and at least photoactivatable agent that absorbs and emits light between about 400 nm and about 800 nm.

Abstract: The present document describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for use in the treatment of skin and soft tissue wounds that have either or both non-resistant and resistant infections.

Abstract: The present document describes methods of using compositions for inhibiting biofilm formation, or disrupting existing or developing biofilms in a subject, which composition comprises at least one chromophore and a pharmacologically acceptable carrier.

Abstract: Enzyme-based biofuel cells including a bioanode, a biocathode, and an electrolyte solution are disclosed. The bioanode contains (a) a conductive substrate; (b) one or more n-type polymers; and (c) one or more enzymes. The biocathode contains (a) a conductive substrate; and (b) one or more p-type polymers. The electrolyte solution contains one or more metabolites capable of reacting with the enzymes and is in electrical communication with the bioanode and the biocathode. The bioanode is electrically connected to the biocathode. The biofuel generates power when the metabolites react with the enzymes to produce electrons; the electrons are directed through an electrical circuit to the biocathode where an oxidant is reduced to water. The structure of the n-type polymer allows for efficient electron transfer from the enzyme to the polymer, resulting improved biofuel cell performances. Methods of making and using the enzyme-based biofuel cells are also disclosed.

Abstract: The present disclosure provides biophotonic topical compositions, kits and their uses. In some aspects, the biophotonic topical compositions of the present disclosure comprise a first chromophore, a salt selected from one or more bicarbonate or carbonate salts or a combination of the foregoing salts, and one or more gelling agents. In some aspects, the biophotonic topical compositions of the present disclosure comprise a first chromophore, one or more polyols, and one or more gelling agents. The biophotonic compositions of the present disclosure do not include an oxidant selected from the group consisting of a peroxide, a peroxy acid, hydrogen peroxide, carbamide peroxide, an alkali metal peroxide, an alkali metal percarbonate, peroxyacetic acid, and an alkali metal perborate. The biophotonic compositions are useful for promoting wound healing and skin rejuvenation, as well as treating acne and various skin disorders.

Abstract: The present document describes methods of using compositions for inhibiting biofilm formation, or disrupting existing or developing biofilms in a subject, which composition comprises at least one chromophore and a pharmacologically acceptable carrier.

Abstract: The present disclosure describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for the treatment of otitis externa.

Abstract: The present disclosure provides biophotonic topical compositions, kits and their uses. In some aspects, the biophotonic topical compositions of the present disclosure comprise a first chromophore, a salt selected from one or more bicarbonate or carbonate salts or a combination of the foregoing salts, and one or more gelling agents. In some aspects, the biophotonic topical compositions of the present disclosure comprise a first chromophore, one or more polyols, and one or more gelling agents. The biophotonic compositions of the present disclosure do not include an oxidant selected from the group consisting of a peroxide, a peroxy acid, hydrogen peroxide, carbamide peroxide, an alkali metal peroxide, an alkali metal percarbonate, peroxyacetic acid, and an alkali metal perborate. The biophotonic compositions are useful for promoting wound healing and skin rejuvenation, as well as treating acne and various skin disorders.

Abstract: The present technology generally relates to an absorbent biophotonic fiber system and to articles comprising the absorbent biophotonic fiber system as well as to the potential uses thereof, such as, for example, in wound treatment.

Abstract: Antitoxic fibers and fabrics contain impregnated material including an antitoxin. A method for producing antitoxic fabric and products includes impregnating a fabric formed from nonpolymeric or polymeric fibers by fully immersing the fabric in a solution of a concentrate of triiodide and an additive portion that includes an oil of ethoxylated fatty acids in sufficient proportion to stabilize the triiodide in the fabric. An antitoxic fabric includes polymeric or nonpolymeric fibers and impregnated material, which includes an antitoxin, the antitoxin being triiodide, and additional chemical components including an oil of ethoxylated fatty acids in sufficient proportion to stabilize the triiodide in the antitoxic fabric. The antitoxic fabric is efficacious on contact, and maintains efficacy with negligible toxicity in use.

Abstract: Antitoxic fibers and fibrous media contain impregnated material including an antitoxin. A method for producing antitoxic fibers and fibrous media includes impregnating a fibrous media by dipping in a dipping solution containing a concentrate of an antitoxin to form a fiber with impregnated material including an antitoxin. The impregnated material is at least about 1.0% to about 2.5% by weight of the fibers and includes additive chemical components including at least one of an anionic, cationic or nonionic component, an oil and/or an organic solvent, and an alcohol. The additives include those found in a spin finish. The antitoxin is in an amount of at least 0.1% by weight of the fiber. The manufacturing process can be applied to any woven or nonwoven media.

Abstract: The present disclosure generally relates to methods and processes for modulating biophotonic regimens as well as to the modulated biophotonic regimens resulting therefrom. The present disclosure also generally relates to biophotonic methods for stimulating energy production in a tissue.

Abstract: The present disclosure describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for the treatment of otitis externa.

Abstract: The present disclosure describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for the treatment of otitis externa.

Abstract: The present technology generally relates to products, devices, methods and systems for healing of wounds or for wound-treatment therapies. More particularly, but not by way of limitation, the present technology relates an absorbent product impregnated with photoactivatable agents, or light-absorbing molecules, as photoactivatable inserts as wound dressing that can be used together as part of negative-pressure wound therapy (NPWT) system or separately and without the NPWT system.

Abstract: An anti-rotation device for suspending a load under a machine for lifting and moving this load includes a sling system provided with a fastener to the machine. It further includes a spreader beam, having a main longitudinal axis and a yaw rotation vertical transverse axis, including: a system for upper fastening to the sling system so it can be suspended in a substantially horizontal arrangement of its main longitudinal axis and free about its vertical transverse axis under the machine using the sling system; a system for lower fastening to the load, allowing driving of the load by the spreader beam about its vertical transverse axis. The spreader beam includes a propulsion unig disposed in such a way as to engage its rotation, selectively in one direction or in the other, about its vertical transverse axis when it is suspended from the machine via the sling system.